Agencies want their procurement partners to co-create with them along every step of the process, rather than simply providing ...

B2B healthcare engagement is at an inflection point. Precision targeting and information delivery is being reshaped by ...

As part of the leadership changes, Joanna Ruiz and Megan Skelly have departed Havas Lynx, while Bruno Rebelo has joined as ...

New research from Ideally reveals the cultural impact of GLP-1 drugs and the significance of brand repositioning in response ...

FDA panel narrowly sides with RFK Jr. on peptides; Cyclosporiasis outbreak continues to expand; Biotech is back!

The new features across campaign optimisation and measurement may see ChatGPT Ads competing more directly with the likes of ...

RFK Jr.’s pharma ad ban plans are slowing; Johnson & Johnson to pay $5.5 billion for talc product lawsuit settlement; HIV ...

Bristol Myers Squibb announced it will work with Nvidia to roll out the industry’s “most powerful” AI computing buildout, ...

The quarterly report is the third since the close of Omnicom’s acquisition of rival holding company Interpublic Group last ...

The FDA is urged by advocacy group to ban DTC prescription drug ads; Peptide panel review stretches into second day; Eli ...

The Trump administration has effectively shut down most of the Agency for Healthcare Research and Quality’s activities, closing the spigot on federal funding estimated to have saved thousands of lives ...

As drugmakers introduce more advanced treatments for chronic disease, pet owners are entering the prescribing conversation. Yet if the infrastructure to help them pay for those treatments doesn’t keep ...